Market Tracker

08/29 6:01pm ET

CytRx Corp (NASDAQ:CYTR)

3.32
Data as of Aug 29
 -0.05 / -1.48%
Today’s Change
2.00
Today|||52-Week Range
8.35
-47.05%
Year-to-Date

Today’s Trading

Previous close3.37
Today’s open3.39
Day’s range3.27 - 3.42
Volume519,309
Average volume (3 months)1,355,207
Market cap$185.1M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-84.62%
Earnings growth (this year)+55.23%
Earnings growth (next 5 years)--
Revenue growth (last year)+200.00%
P/E ratioNM
Price/Sales687.43
Price/Book13.07

Competitors

 Today’s
change
Today’s
% change
PSTIPluristem Therapeuti...-0.03-1.04%
ICELCellular Dynamics In...+0.99+9.47%
PTIEPain Therapeutics In...+0.01+0.24%
ENZYEnzymotec Ltd-0.11-1.24%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$300.0K
Annual profit (last year)-$47.5M
Net profit margin-15,828.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts